GC Biopharma (006280.KS) Earnings Analysis
GC Biopharma (006280.KS) has no confirmed upcoming earnings date. Last quarter (2026-05-08) it beat with EPS 1,751.52 KRW vs -126.2 KRW est (+1487.9%). It has beaten estimates in 4/7 recent quarters (57%). Trailing P/E -101.12.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 006280.KS next report earnings?
No confirmed upcoming earnings date is currently scheduled for 006280.KS. This page updates as the calendar is published.
006280.KS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-08 | 1,751.52 KRW | -126.2 KRW | +1487.9% | Beat |
| 2026-01-26 | -7,555.4 KRW | -3,201.46 KRW | -136% | Miss |
| 2025-08-01 | 3,328.58 KRW | 1,312.9 KRW | +153.5% | Beat |
| 2025-04-30 | 2,602 KRW | -1,049.15 KRW | +348% | Beat |
| 2025-01-24 | -2,391.48047 KRW | 759 KRW | -415.1% | Miss |
| 2024-11-01 | 2,915 KRW | 1,005 KRW | +190% | Beat |
| 2024-08-05 | -608 KRW | 758.94 KRW | -180.1% | Miss |
Beat rate: 4/7 (57%) over reported quarters with consensus data.
006280.KS valuation and analyst view
| Trailing P/E | -101.12 |
|---|---|
| Trailing EPS | -1,212.63583 KRW |
| Price / book | 1.15 |
| Dividend yield | 1.22% |
| Market cap | 1354.74B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is GC Biopharma (006280.KS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 006280.KS. This page updates as the calendar is published.
Did 006280.KS beat earnings last quarter?
In its 2026-05-08 report, 006280.KS posted EPS of 1751.52 KRW versus a -126.2 KRW estimate — a beat of 1487.9%.
What is 006280.KS's earnings track record?
Over the last 7 reported quarters with consensus data, 006280.KS beat estimates 4 times (57%).
What is 006280.KS's current P/E ratio and EPS?
006280.KS trades at a trailing P/E of -101.12 on trailing EPS of -1212.6358320970417 KRW.
What do analysts rate 006280.KS?
006280.KS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.